Tarvin v. Olly Pub. Ben. Corp., 2024 WL 4866271, --- F.Supp.3d ----, No. 2:24-cv-06261-WLH-PD (C.D. Cal. Nov. 12, 2024)
Olly makes dietary supplements, e.g., “Sleep Extra Strength
Melatonin 5 mg.” Each product includes the dosage amount and the net quantity
of units per container on its front label. But, unlike some other brands, Olly
Products do not state the serving size on the front label or that the dosage
amount is per serving. Serving size and servings per container information is on
the back label. This means that a consumer must ingest two units of gummies of
Olly Extra Strength Sleep Product, rather than one, to obtain the 5 mg of
melatonin that is advertised on the product’s front label. Tarvin brought the usual
California statutory and other claims.
Statutory claims: Would a reasonable consumer have consulted
the back label? This wasn’t the rare situation in which the claim could be
dismissed on the pleadings. In addition to the labels themselves, Tarvin pled images
of competitor labels as points of comparison to demonstrate “appropriate
labeling conduct” and establish the expectations of a reasonable consumer. Misleadingness
was plausible.
Olly argued that the labels were at most ambiguous, and that
consumers are required to consult the back in cases of ambiguity. But a front
label may be “unambiguously deceptive” for Rule 12(b)(6) purposes “even if it
has two possible meanings, so long as the plaintiff has plausibly alleged that
are reasonable consumer would view the label as having one unambiguous (and
deceptive) meaning.” Representation of dosage amount on the front label without
qualifying serving information may be considered “unambiguously deceptive” on a
motion to dismiss.
Warranty claims, however, failed for want of an unequivocal
promise that the dosage was per gummy. Likewise, negligent and intentional
misrepresentation claims failed, because they required actual falsity: a
“perfectly true statement couched in such a manner that is likely to mislead or
deceive the consumer, such as by failure to disclose other relevant
information” may be actionable under consumer protection statutes but not
common law fraud.
No comments:
Post a Comment